AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2024

May 23, 2024

34975_dirs_2024-05-23_294e017b-e653-4519-b749-e2fbbf1d1292.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2024-05-21

Reporting Person: LOY BERTRAND (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-21	Common Stock	A	56575	$0.00	Acquired	56575	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	499633	Indirect

Footnotes

F1: Represents an award of 56,575 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 14, 2024, immediately prior to the commencement of such meeting, and (ii) May 21, 2025.